波谱学杂志 ›› 2009, Vol. 26 ›› Issue (1): 120-125.

• 研究简报 • 上一篇    下一篇

新药替尼泊苷的碳氢NMR信号全归属

李文*; 沙沂; 朱丹   

  1. (沈阳药科大学 分析测试中心,辽宁 沈阳 110016)
  • 收稿日期:2008-09-26 修回日期:2008-10-14 出版日期:2009-03-05 发布日期:2009-12-05
  • 通讯作者: 李文

Assignment of 13C and 1H Chemical Shifts of Teniposide

LI Wen*; SHA Yi; ZHU Dan   

  1. (Center of Instrumental Analysis, Shenyang Pharmaceutical University, Shenyang 110016, China)
  • Received:2008-09-26 Revised:2008-10-14 Online:2009-03-05 Published:2009-12-05
  • Contact: LI Wen

摘要: 替尼泊苷是从北美鬼臼或西藏鬼臼提取到的鬼臼树脂,经化学成分分离得到鬼臼毒素通过半合成方法获得的衍生物,是一种周期特异性细胞毒药物.作为一种抗肿瘤药物,替尼泊苷已逐渐成为治疗颅内恶性肿瘤的主要化疗药物.本文应用1D NMR和2D NMR实验技术(COSY,NOESY,TOCOSY,gHSQC,gHMBC)研究了其结构,并对其1H NMR、13C NMR谱信号进行了全归属.

关键词: 归属, 核磁共振(NMR), 2D NMR技术, 替尼泊苷, 抗肿瘤药

Abstract: Teniposide is a semisynthetic podophyllotoxin obtainable from the extracts of the roots and the rhizomes of May apple or mandrake plant Podophyllum peltatum. As an anticancer agent, Teniposide has become a major chemotherapy drug for the treatment of intracranial malignant tumor. In this study, the 13C and 1H chemical shifts of the compound were assigned using 1D NMR and 2D NMR techniques including COSY, TOCOSY, NOESY, gHSQC and gHMBC. Its structure was determined from the NMR data.

Key words: NMR, assignments, 2D NMR, teniposide, anti-tumor drug

中图分类号: